An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs

Adeno-associated virus (AAV) vectors have been successfully applied in hemophilia clinical trials. However, this approach is limited to patients without AAV-neutralizing antibodies (NAbs). In this study, we explored the feasibility of AAV re-administration in hemophilia A dogs treated initially 8 ye...

Description complète

Détails bibliographiques

Auteurs principaux:	Junjiang Sun, Wenwei Shao, Xiaojing Chen, Elizabeth P. Merricks, Lauren Wimsey, Yasmina L. Abajas, Glenn P. Niemeyer, Clinton D. Lothrop, Paul E. Monahan, R. Jude Samulski, Timothy C. Nichols, Chengwen Li
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2018-09-01
Collection:	Molecular Therapy: Methods & Clinical Development
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2329050118300755
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!